FUM - FUTURA MEDICAL - Share Chat

Futura Medical plc is an AIM-listed pharmaceutical company focused on developing innovative, topical treatments for sexual health conditions. Its flagship product is Eroxon® (MED3000), a rapidly acting, topically applied gel for erectile dysfunction (ED). Eroxon offers a unique, non-prescription alternative to oral ED medications, designed for discreet and convenient use.

The company achieved a significant milestone with US FDA approval for Eroxon in 2023, making it the first over-the-counter topical ED treatment available in the US without a prescription. It also holds CE Mark approval in Europe. Futura operates a licensing and distribution business model, partnering with established pharmaceutical and consumer healthcare companies globally to commercialise Eroxon, leveraging their market reach and infrastructure for sales and marketing.